Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-063173)

Filing Details

Accession Number:: 0001209191-14-063173
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-10-14 20:00:22
Reporting Period:: 2014-10-10

Filing Date:: 2014-10-14
Accepted Time:: 2014-10-14 20:00:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1001233	Sangamo Biosciences Inc	SGMO	Biological Products, (No Disgnostic Substances) (2836)	680359556

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1302390	Ward Henry Wolff	C/O Sangamo Biosciences Inc., Point Richmond Tech Cntr, 501 Canal Blvd Richmond CA 94804	Exec Vp & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-10-10	2,000	$10.10	214,347	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2014.
Includes 50,000 shares, 30,000 shares, and 35,000 shares subject to RSUs granted on December 8, 2011, December 6, 2012, and December 12, 2013, respectively, that will be issued as such units vest in accordance with their terms.